The present disclosure provides the 2,4-pyrimidinediamine compound shown below, compositions comprising the compound, intermediates and methods for synthesizing the compound, and methods of using the compound in a variety of applications including treatment of autoimmune diseases. ##STR00001##

 
Web www.patentalert.com

< Antineoplastic combinations

> Molecular beacons, methods and kits for detecting DNA damage response

> Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereof

~ 00535